drugset / Trial / NCT06471998

Evaluation of the Benefit and Safety of Localized Tissue Hydration in the Management of Chronic Low Back Pain

NCT06471998

Phase 2 Completed 30 enrolled Ramsay Santé Euraxi Pharma · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the benefit of Localized Tissue Hydration associated with standard management of chronic common low back pain, in terms of improvement in the numerical verbal scale score at 6 months.

Timeline

Start
2025-02-28
Primary completion
2026-03-31
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium chloride Unknown 0.9 % Subcutaneous

Indications